Pramod K Giri

Summary

Affiliation: University of Notre Dame
Country: USA

Publications

  1. ncbi Is intranasal vaccination a feasible solution for tuberculosis?
    Pramod K Giri
    Postdoctoral Research Associate, Eck Center for Global Health and Infectious Disease, Dept of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA
    Expert Rev Vaccines 7:1341-56. 2008
  2. ncbi How could we have better vaccines against tuberculosis?
    Pramod K Giri
    University of Notre Dame, Eck Center for Global Health and Infectious Disease, Department of Biological Sciences, Notre Dame, IN 46556, USA
    Expert Opin Biol Ther 8:1759-72. 2008
  3. ncbi Adjunct immunotherapy with Ag85 complex proteins based subunit vaccine in a murine model of Mycobacterium tuberculosis infection
    Pramod K Giri
    University of Notre Dame, IN, USA
    Immunotherapy 1:31-7. 2009

Collaborators

Detail Information

Publications3

  1. ncbi Is intranasal vaccination a feasible solution for tuberculosis?
    Pramod K Giri
    Postdoctoral Research Associate, Eck Center for Global Health and Infectious Disease, Dept of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA
    Expert Rev Vaccines 7:1341-56. 2008
    ..This article will focus on the potential of intranasal vaccination and mucosal adjuvants for the development of new-generation TB vaccines...
  2. ncbi How could we have better vaccines against tuberculosis?
    Pramod K Giri
    University of Notre Dame, Eck Center for Global Health and Infectious Disease, Department of Biological Sciences, Notre Dame, IN 46556, USA
    Expert Opin Biol Ther 8:1759-72. 2008
    ..One-third of the world's population is now infected with the TB bacillus. According to the WHO, an estimated 1.7 million people died from TB in 2006. More precisely, every 15 seconds, one person dies due to TB worldwide...
  3. ncbi Adjunct immunotherapy with Ag85 complex proteins based subunit vaccine in a murine model of Mycobacterium tuberculosis infection
    Pramod K Giri
    University of Notre Dame, IN, USA
    Immunotherapy 1:31-7. 2009
    ..In conclusion, this study shows that Ag85AB-CpG-DDA formulation may act as a potential future therapeutic regimen in conjunction with antituberculous drugs...